It is an important point but we cant at the moment say anything about that, he said. The study was not set up to look at any differences between the two. The Pfizer/BioNTech was available first so there is more data, but the Oxford/AstraZeneca was mostly used in the older age group. That rose to more than 85% after the second dose. The numbers were very small and there was uncertainty over their significance, said the researchers.
Mark's dog found that there are significant differences between the two studies.
( z0 find :ARG0 ( z1 dog :poss ( z2 person :name ( z3 name :op "Mark" ) ) ) :ARG1 ( z4 differ :ARG1 ( z5 study :quant 2 ) :ARG1-of ( z6 significant ) ) )
(z0 / find-01
    :ARG0 (z1 / dog
              :poss (z2 / person
                        :name (z3 / name
                                  :op1 "Mark")))
    :ARG1 (z4 / differ-02
              :ARG1 (z5 / study-01
                        :quant 2)
              :ARG1-of (z6 / significant-02)))
Mark 's dog found that there are significant differences between the two studies .
z2 :name z3
z3 :op1 1
z1 :poss z2
z0 :ARG0 z1
z4 :ARG1-of z6
z0 :ARG1 z4
z5 :quant 0
z4 :ARG1 z5